These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 11385272
1. Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome. Dressler D, Wittstock M, Benecke R. Eur Neurol; 2001; 45(4):287-8. PubMed ID: 11385272 [No Abstract] [Full Text] [Related]
2. Botulinum toxin physiology in focal hand and cranial dystonia. Karp BI. Toxins (Basel); 2012 Nov 20; 4(11):1404-14. PubMed ID: 23202323 [Abstract] [Full Text] [Related]
8. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis. Dadgardoust PD, Rosales RL, Asuncion RM, Dressler D. J Neural Transm (Vienna); 2019 Feb 20; 126(2):141-148. PubMed ID: 30604200 [Abstract] [Full Text] [Related]
9. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia. Yoshida K. Toxins (Basel); 2021 Aug 29; 13(9):. PubMed ID: 34564609 [Abstract] [Full Text] [Related]
10. Treatment of inferior lateral pterygoid muscle dystonia with zolpidem tartrate, botulinum toxin injections, and physical self-regulation procedures: a case report. Vazquez-Delgado E, Okeson JP. Cranio; 2004 Oct 29; 22(4):325-9. PubMed ID: 15532318 [Abstract] [Full Text] [Related]
11. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block. Bianchini E, Massimiani A, Bemporad J, Giovannelli M. Acta Neurol Belg; 2024 Jun 29; 124(3):1095-1097. PubMed ID: 38133850 [No Abstract] [Full Text] [Related]